Screening studies of antimicrobial activity of pyrimidine derivative

Aim of the study was to screen the antimicrobial activity of pyrimidine derivative 3-[2-(1-naphthyl)-2-oxoethyl]-6-bromoquinazoline-4(3H)-oh with laboratory cipher VMA–13–06 in relation to pathogenic and opportunistic flora. Material and methods. Antimicrobial activity of VMA–13–06 was established i...

Full description

Bibliographic Details
Main Authors: A. A. Tsibizova, A. L. Yasenyavskaya, A. A. Ozerov, I. N. Tyurenkov, O. A. Bashkina, M. A. Samotrueva
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2021-12-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/698
_version_ 1797269552346693632
author A. A. Tsibizova
A. L. Yasenyavskaya
A. A. Ozerov
I. N. Tyurenkov
O. A. Bashkina
M. A. Samotrueva
author_facet A. A. Tsibizova
A. L. Yasenyavskaya
A. A. Ozerov
I. N. Tyurenkov
O. A. Bashkina
M. A. Samotrueva
author_sort A. A. Tsibizova
collection DOAJ
description Aim of the study was to screen the antimicrobial activity of pyrimidine derivative 3-[2-(1-naphthyl)-2-oxoethyl]-6-bromoquinazoline-4(3H)-oh with laboratory cipher VMA–13–06 in relation to pathogenic and opportunistic flora. Material and methods. Antimicrobial activity of VMA–13–06 was established in vitro against strains of Staphylococcus aureus, Klebsiella pneumonia, Streptococcus pyogenes, Escherichia coli, Acinetobacter baumannii and Citrobacter freundii by the method of serial dilutions, by forming rows with different concentrations of the compound under study. Results. VMA–13–06 was found to exhibit high antibacterial activity against S. aureus, S. pyogenes, E. coli and K. pneumonia at concentrations of 128 and 64 μg/ml comparable to the activity of the comparison drug norfloxacin. At a concentration of 32 μg/ml, the studied derivative is highly active against S. aureus and S. pyogenes and shows average activity against E. coli and K. pneumonia. The compound VMA–13–06 in dilution from 16 to 4 μg/ml is moderately active against the above-mentioned microorganisms. At concentrations from 2 to 0.25 μg/ml, the pyrimidine derivative is inactive against S. aureus, S. pyogenes, E. coli and K. pneumonia, in all dilutions – against C. freundii and A. baumannii. Conclusions. The results of a screening study indicate a pronounced bactericidal effect of VMA–13–06 against S. aureus, S. pyogenes, E. coli и K. pneumonia comparable to the comparison drug norfloxacin.
first_indexed 2024-03-08T14:33:16Z
format Article
id doaj.art-b97d7233193041558087487b9ecf37b2
institution Directory Open Access Journal
issn 2410-2512
2410-2520
language Russian
last_indexed 2024-04-25T01:50:11Z
publishDate 2021-12-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj.art-b97d7233193041558087487b9ecf37b22024-03-07T18:50:00ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202021-12-01416566010.18699/SSMJ20210606394Screening studies of antimicrobial activity of pyrimidine derivativeA. A. Tsibizova0A. L. Yasenyavskaya1A. A. Ozerov2I. N. Tyurenkov3O. A. Bashkina4M. A. Samotrueva5Astrakhan State Medical University of Minzdrav of RussiaAstrakhan State Medical University of Minzdrav of RussiaVolgograd State Medical University of Minzdrav of RussiaVolgograd State Medical University of Minzdrav of RussiaAstrakhan State Medical University of Minzdrav of RussiaAstrakhan State Medical University of Minzdrav of RussiaAim of the study was to screen the antimicrobial activity of pyrimidine derivative 3-[2-(1-naphthyl)-2-oxoethyl]-6-bromoquinazoline-4(3H)-oh with laboratory cipher VMA–13–06 in relation to pathogenic and opportunistic flora. Material and methods. Antimicrobial activity of VMA–13–06 was established in vitro against strains of Staphylococcus aureus, Klebsiella pneumonia, Streptococcus pyogenes, Escherichia coli, Acinetobacter baumannii and Citrobacter freundii by the method of serial dilutions, by forming rows with different concentrations of the compound under study. Results. VMA–13–06 was found to exhibit high antibacterial activity against S. aureus, S. pyogenes, E. coli and K. pneumonia at concentrations of 128 and 64 μg/ml comparable to the activity of the comparison drug norfloxacin. At a concentration of 32 μg/ml, the studied derivative is highly active against S. aureus and S. pyogenes and shows average activity against E. coli and K. pneumonia. The compound VMA–13–06 in dilution from 16 to 4 μg/ml is moderately active against the above-mentioned microorganisms. At concentrations from 2 to 0.25 μg/ml, the pyrimidine derivative is inactive against S. aureus, S. pyogenes, E. coli and K. pneumonia, in all dilutions – against C. freundii and A. baumannii. Conclusions. The results of a screening study indicate a pronounced bactericidal effect of VMA–13–06 against S. aureus, S. pyogenes, E. coli и K. pneumonia comparable to the comparison drug norfloxacin.https://sibmed.elpub.ru/jour/article/view/698pyrimidine derivativesantimicrobial activitybactericidal effectbacteriostatic effect
spellingShingle A. A. Tsibizova
A. L. Yasenyavskaya
A. A. Ozerov
I. N. Tyurenkov
O. A. Bashkina
M. A. Samotrueva
Screening studies of antimicrobial activity of pyrimidine derivative
Сибирский научный медицинский журнал
pyrimidine derivatives
antimicrobial activity
bactericidal effect
bacteriostatic effect
title Screening studies of antimicrobial activity of pyrimidine derivative
title_full Screening studies of antimicrobial activity of pyrimidine derivative
title_fullStr Screening studies of antimicrobial activity of pyrimidine derivative
title_full_unstemmed Screening studies of antimicrobial activity of pyrimidine derivative
title_short Screening studies of antimicrobial activity of pyrimidine derivative
title_sort screening studies of antimicrobial activity of pyrimidine derivative
topic pyrimidine derivatives
antimicrobial activity
bactericidal effect
bacteriostatic effect
url https://sibmed.elpub.ru/jour/article/view/698
work_keys_str_mv AT aatsibizova screeningstudiesofantimicrobialactivityofpyrimidinederivative
AT alyasenyavskaya screeningstudiesofantimicrobialactivityofpyrimidinederivative
AT aaozerov screeningstudiesofantimicrobialactivityofpyrimidinederivative
AT intyurenkov screeningstudiesofantimicrobialactivityofpyrimidinederivative
AT oabashkina screeningstudiesofantimicrobialactivityofpyrimidinederivative
AT masamotrueva screeningstudiesofantimicrobialactivityofpyrimidinederivative